HLA-F Surface Expression on B Cell and Monocyte Cell Lines Is Partially Independent from Tapasin and Completely Independent from TAP

Journal of Immunology

Volumn 171, Issue 10, 2003, Pages 5264-5271

  Lee, Ni ^a   Geraghty, Daniel E ^a  

^a Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; ENDOGLYCOSIDASE H; GLYCOSIDASE; HLA ANTIGEN CLASS 1; HLA F ANTIGEN; PROTEIN; TAP PROTEIN; TAPASIN; UNCLASSIFIED DRUG;

ANTIGEN EXPRESSION; ARTICLE; B LYMPHOBLASTOID CELL LINE; B LYMPHOCYTE; BLADDER; CELL LINE; CELL SURFACE; COLD TREATMENT; DELETION MUTANT; GENETICS; GLYCOSYLATION; HUMAN; HUMAN CELL; LIVER CELL; LYMPHOBLASTOID CELL; LYMPHOID CELL LINE; MAJOR HISTOCOMPATIBILITY COMPLEX; MOLECULAR STABILITY; MONOCYTE; PHENOTYPE; PRIORITY JOURNAL; SKIN CELL;

EID: 0242579843     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.10.5264     Document Type: Article

References (54)

1. Accolla, R. S., L. Adorini, S. Sartoris, F. Sinigaglia, and J. Guardiola. 1995. MHC: orchestrating the immune response. Immunol. Today 16:8.
2. Lanier, L. L., and J. H. Phillips. 1995. NK cell recognition of major histocompatibility complex class I molecules. Semin. Immunol. 7:75.
3. Colonna, M. 1996. Natural killer cell receptors specific for MHC class 1 molecules. Curr. Opin. Immunol. 8:101.
4. Spies, T., and R. DeMars. 1991. Restored expression of major histocompatibility class I molecules by gene transfer of a putative peptide transporter. Nature 351:323.
5. Spies, T., V. Cerundolo, M. Colonna, P. Cresswell, A. Townsend, and R. DeMars. 1992. Presentation of viral antigen by MHC class I molecules is dependent on a putative peptide transporter heterodimer. Nature 355:644.
6. Geraghty, D. E., B. H. Koller, J. A. Hansen, and H. T. Orr. 1992. The HLA class I gene family includes at least six genes and twelve pseudogenes and gene fragments. J. Immunol. 149:1934.
7. Koller, B. H., D. Geraghty, H. T. Orr, Y. Shimizu, and R. DeMars. 1987. Organization of the human class I major histocompatibility complex genes. Immunol. Res. 6:1.
8. Geraghty, D. E. 1993. Structure of the HLA class I region and expression of its resident genes. Curr. Opin. Immunol. 5:3.
9. Little, A. M., and P. Parham. 1999. Polymorphism and evolution of HLA class I and II genes and molecules. Rev. Immunogenet. 1:105.
10. Hughes, A. L., and M. Nei. 1988. Pattern of nucleotide substitution at major histocompatibility complex class 1 loci reveals overdominant selection. Nature 335:167.
11. Ishitani, A., N. Sageshima, N. Lee, N. Dorofeeva, K. Hatake, H. Marquardt, and D. E. Geraghty. 2003. Protein expression and peptide binding suggest unique and interacting functional roles for HLA-E, F, and G in maternal-placental immune recognition. J. Immunol. 171:1376.
12. Ponte, M., C. Cantoni, R. Biassoni, A. Tradori-Cappai, G. Bentivoglio, C. Vitale, S. Bertone, A. Moretta, L. Moretta, and M. C. Mingari. 1999. Inhibitory receptors sensing HLA-G1 molecules in pregnancy: decidua-associated natural killer cells express LIR-1 and CD94/NKG2A and acquire p49, an HLA-G1-specific receptor. Proc. Natl. Acad. Sci. USA 96:5674.
13. Rajagopalan, S., and E. O. Long. 1999. A human histocompatibility leukocyte antigen (HLA)-G-specific receptor expressed on all natural killer cells. J. Exp. Med. 189:1093.
14. Navarro, F., M. Llano, T. Bellon, M. Colonna, D. E. Geraghty, and M. Lopez-Botet. 1999. The ILT2(LIR1) and CD94/NKG2A NK cell receptors respectively recognize HLA-G1 and HLA-E molecules co-expressed on target cells. Eur. J. Immunol. 29:277.
15. Colonna, M., J. Samaridis, M. Cella, L. Angman, R. L. Allen, C. A. O'Callaghan, R. Dunbar, G. S. Ogg, V. Cerundolo, and A. Rolink. 1998. Human myelomonocytic cells express an inhibitory receptor for classical and nonclassical MHC class I molecules. J. Immunol. 160:3096.
16. Lee, N., D. R. Goodlett, A. Ishitani, H. Marquardt, and D. E. Geraghty. 1998. HLA-E surface expression depends on binding of TAP-dependent peptides derived from certain HLA class I signal sequences. J. Immunol. 160:4951.
17. Braud, V. M., D. S. Allan, C. A. O'Callaghan, K. Soderstrom, A. D'Andrea, G. S. Ogg, S. Lazetic, N. T. Young, J. I. Bell, J. H. Phillips, et al. 1998. HLA-E binds to natural killer cell receptors CD94/NKG2A, B and C. Nature 391:795.
18. Lee, N., M. Llano, M. Carretero, A. Ishitani, F. Navarro, M. Lopez-Botet, and D. E. Geraghty. 1998. HLA-E is a major ligand for the natural killer inhibitory receptor CD94/NKG2A. Proc. Natl. Acad. Sci. USA 95:5199.
19. O'Callaghan, C. A., J. Tormo, B. E. Willcox, V. M. Braud, B. K. Jakobsen, D. I. Stuart, A. J. McMichael, J. I. Bell, and E. Y. Jones. 1998. Structural features impose tight peptide binding specificity in the nonclassical MHC molecule HLA-E. Mol. Cell 1:531.
20. Strong, R. K., M. A. Holmes, P. Li, L. Braun, N. Lee, and D. E. Geraghty. 2003. HLA-E allelic variants: correlating differential expression, peptide affinities, crystal structures and thermal stabilities. J. Biol. Chem. 278:5082.
21. Geraghty, D. E., X. H. Wei, H. T. Orr, and B. H. Koller. 1990. Human leukocyte antigen F (HLA-F). An expressed HLA gene composed of a class I coding sequence linked to a novel transcribed repetitive element. J. Exp. Med. 171:1.
22. Wainwright, S. D., P. A. Biro, and C. H. Holmes. 2000. HLA-F is a predominantly empty, intracellular. TAP-associated MHC class Ib protein with a restricted expression pattern. J. Immunol. 164:319.
23. Lepin, E. J., J. M. Bastin, D. S. Allan, G. Roncador, V. M. Braud, D. Y. Mason, P. A. van der Merwe, A. J. McMichael, J. I. Bell, S. H. Powis, et al. 2000. Functional characterization of HLA-F and binding of HLA-F tetramers to ILT2 and ILT4 receptors. Eur. J. Immunol. 30:3552.
24. Lee, N., A. R. Malacko, A. Ishitani, M. C. Chen, J. Bajorath, H. Marquardt, and D. E. Geraghty. 1995. The membrane-bound and soluble forms of HLA-G bind identical sets of endogenous peptides but differ with respect to TAP association. Immunity 3:591.
25. Spector, D. L., R. D. Goldman, and L. A. Leinwand. 1988. Cells: A Laboratory Manual, Vol. 1: Culture and Biochemical Analysis of Cells. Cold Spring Harbor Laboratory Press. Cold Spring Harbor, p. 7.4.
26. Shimizu, Y., and R. DeMars. 1989. Production of human cells expressing individual transferred HLA-A, -B, -C genes using an HLA-A, -B, -C null human cell line. J. Immunol. 142:3320.
27. Grandea, A. G., III, M. J. Androlewicz, R. S. Athwal, D. E. Geraghty, and T. Spies. 1995. Dependence of peptide binding by MHC class I molecules on their interaction with TAP. Science 270:105.
28. Schatz, P. J. 1993. Use of peptide libraries to map the substrate specificity of a peptide-modifying enzyme: a 13 residue consensus peptide specifies biotinylation in Escherichia coli. Bio/Technology 11:1138.
29. Shimizu, Y., D. E. Geraghty, B. H. Koller, H. T. Orr, and R. DeMars. 1988. Transfer and expression of three cloned human non-HLA-A, B, C class 1 major histocompatibility complex genes in mutant lymphoblastoid cells. Proc. Natl. Acad. Sci. USA 85:227.
30. Ljunggren, H. G., N. J. Stam, C. Ohlen, J. J. Neefjes, P. Hoglund, M. T. Heemels, J. Bastin, T. N. Schumacher, A. Townsend, K. Karre, et al. 1990. Empty MHC class I molecules come out in the cold. Nature 346:476.
31. Shimizu, Y., B. Koller, D. Geraghty, H. Orr, S. Shaw, P. Kavathas, and R. DeMars. 1986. Transfer of cloned human class I major histocompatibility complex genes into HLA mutant human lymphoblastoid cells. Mol. Cell. Biol. 6:1074.
32. Lury, D., H. Epstein, and N. Holmes. 1990. The human class I MHC gene HLA-F is expressed in lymphocytes. Int. Immunol. 2:531.
33. Neisig, A., R. Wubbolts, X. Zang, C. Melief, and J. Neefjes. 1996. Allele-specific differences in the interaction of MHC class I molecules with transporters associated with antigen processing. J. Immunol. 156:3196.
34. Kulig, K., D. Nandi, I. Bacik, J. J. Monaco, and S. Vukmanovic. 1998. Physical and functional association of the major histocompatibility complex class I heavy chain alpha3 domain with the transporter associated with antigen processing. J. Exp. Med. 187:865.
35. Peace-Brewer, A. L., L. G. Tussey, M. Matsui, G. Li, D. G. Quinn, and J. A. Frelinger. 1996. A point mutation in HLA-A*0201 results in failure to bind the TAP complex and to present virus-derived peptides to CTL. Immunity 4:505.
36. Lewis, J. W., A. Neisig, J. Neefjes, and T. Elliott. 1996. Point mutations in the alpha 2 domain of HLA-A2.1 define a functionally relevant interaction with TAP. Curr. Biol. 6:873.
37. O'Callaghan, C. A., and J. I. Bell. 1998. Structure and function of the human MHC class Ib molecules HLA-E, HLA-F and HLA-G. Immunol. Rev. 163:129.
38. Momburg, F., and G. J. Hammerling. 1998. Generation and TAP-mediated transport of peptides for major histocompatibility complex class I molecules. Adv. Immunol. 68:191.
39. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
40. Wyss, D. F., J. S. Choi, and G. Wagner. 1995. Composition and sequence specific resonance assignments of the heterogeneous N-linked glycan in the 13.6 kDa adhesion domain of human CD2 as determined by NMR on the intact glycoprotein. Biochemistry 34:1622.
41. Maresh, G. A., W. C. Wang, K. S. Beam, A. R. Malacko, I. Hellstrom, K. E. Hellstrom, and H. Marquardt. 1994. Differential processing and secretion of the melanoma-associated ME20 antigen. Arch. Biochem. Biophys. 311:95.
42. Shackelford, D. A., and J. L. Strominger. 1983. Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens. J. Immunol. 130:274.
43. Wyss, D. F., J. S. Choi, J. Li, M. H. Knoppers, K. J. Willis, A. R. Arulanandam, A. Smolyar, E. L. Reinherz, and G. Wagner. 1995. Conformation and function of the N-linked glycan in the adhesion domain of human CD2. Science 269:1273.
44. Wyss, D. F., and G. Wagner. 1996. The structural role of sugars in glycoproteins. Curr. Opin. Biotechnol. 7:409.
45. Khandekar, S. S., C. Silverman, J. Wells-Marani, A. M. Bacon, H. Birrell, M. Brigham-Burke, D. J. DeMarini, Z. L. Jonak, P. Camilleri, and J. Fishman-Lobell. 2001. Determination of carbohydrate structures N-linked to soluble CD154 and characterization of the interactions of CD40 with CD154 expressed in Pichia pastoris and Chinese hamster ovary cells. Protein Expression Purif. 23:301.
46. Bartolazzi, A., A. Nocks, A. Aruffo, F. Spring, and I. Stamenkovic. 1996. Glycosylation of CD44 is implicated in CD44-mediated cell adhesion to hyaluronan. J. Cell Biol. 132:1199.
47. Zhang, Z., S. C. Austin, and E. M. Smyth. 2001. Glycosylation of the human prostacyclin receptor: role in ligand binding and signal transduction. Mol. Pharmacol. 60:480.
48. Parham, P. 1996. Functions for MHC class I carbohydrates inside and outside the cell. Trends Biochem. Sci. 21:427.
49. Kornfeld, S., and I. Mellman. 1989. The biogenesis of lysosomes. Annu. Rev. Cell. Biol. 5:483.
50. 2-microglobulin-dependent and independent forms. J. Immunol. 161:1710.
51. 2-microglobulin. J. Biol. Chem. 274:9289.
52. Kang, S. J., and P. Cresswell. 2002. Regulation of intracellular trafficking of human CDId by association with MHC class II molecules. EMBO J. 21:1650.
53. Jayawardena-Wolf, J., K. Benlagha, Y. H. Chiu, R. Mehr, and A. Bendelac. 2001. CDId endosomal trafficking is independently regulated by an intrinsic CDId-encoded tyrosine motif and by the invariant chain. Immunity 15:897.
54. 2-microglobulin-free heavy chain homodimer structure. J. Immunol. 162:5045.